Brave Asset Management Inc Amgen Inc Transaction History

Brave Asset Management Inc

$410 Million
Q3 2024

A detailed history of Brave Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Brave Asset Management Inc holds 2,955 shares of AMGN stock, worth $827,429. This represents 0.23% of its overall portfolio holdings.

Number of Shares

2,955

Previous 3,195 7.51%

Holding current value

$827,429

Previous $998,000 4.61%

% of portfolio

0.23%

Previous 0.25%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$309.38 - $337.38 $74,251 - $80,971	-240 Reduced 7.51%	2,955 $952,000
Q2 2024 Jul 15, 2024	SELL	$262.75 - $319.31 $192,595 - $234,054	-733 Reduced 18.66%	3,195 $998,000
Q1 2024 Apr 29, 2024	SELL	$268.87 - $324.56 $36,028 - $43,491	-134 Reduced 3.3%	3,928 $1.12 Million
Q4 2023 Jan 18, 2024	SELL	$255.7 - $288.46 $6,392 - $7,211	-25 Reduced 0.61%	4,062 $1.17 Million
Q3 2023 Oct 13, 2023	SELL	$218.65 - $271.46 $35,202 - $43,705	-161 Reduced 3.79%	4,087 $1.1 Million
Q2 2023 Jul 24, 2023	BUY	$214.27 - $253.37 $12,641 - $14,948	59 Added 1.41%	4,248 $943,000
Q1 2023 Apr 12, 2023	BUY	$225.79 - $275.2 $270,496 - $329,689	1,198 Added 40.05%	4,189 $1.01 Million
Q4 2022 Jan 19, 2023	SELL	$229.03 - $291.01 $578,758 - $735,382	-2,527 Reduced 45.8%	2,991 $0
Q3 2022 Oct 13, 2022	SELL	$224.46 - $253.15 $10,325 - $11,644	-46 Reduced 0.83%	5,518 $1.24 Million
Q2 2022 Jul 15, 2022	SELL	$230.71 - $256.74 $2,076 - $2,310	-9 Reduced 0.16%	5,564 $1.35 Million
Q1 2022 Apr 22, 2022	SELL	$219.27 - $242.57 $8,332 - $9,217	-38 Reduced 0.68%	5,573 $1.35 Million
Q4 2021 Jan 21, 2022	SELL	$198.88 - $227.6 $3,977 - $4,552	-20 Reduced 0.36%	5,611 $1.26 Million
Q3 2021 Nov 02, 2021	SELL	$212.27 - $248.7 $49,883 - $58,444	-235 Reduced 4.01%	5,631 $1.2 Million
Q2 2021 Jul 27, 2021	SELL	$233.58 - $259.14 $96,702 - $107,283	-414 Reduced 6.59%	5,866 $1.43 Million
Q1 2021 Apr 26, 2021	BUY	$221.91 - $258.6 $288,261 - $335,921	1,299 Added 26.08%	6,280 $1.56 Million
Q4 2020 Jan 27, 2021	SELL	$216.38 - $257.67 $2.01 Million - $2.39 Million	-9,282 Reduced 65.08%	4,981 $1.15 Million
Q3 2020 Oct 19, 2020	BUY	$234.65 - $260.95 $49,745 - $55,321	212 Added 1.51%	14,263 $3.63 Million
Q2 2020 Jul 23, 2020	BUY	$197.81 - $242.74 $171,699 - $210,698	868 Added 6.58%	14,051 $3.31 Million
Q1 2020 Apr 16, 2020	BUY	$182.24 - $241.7 $39,181 - $51,965	215 Added 1.66%	13,183 $2.67 Million
Q4 2019 Jan 17, 2020	BUY	$189.21 - $243.2 $19,488 - $25,049	103 Added 0.8%	12,968 $3.13 Million
Q3 2019 Oct 24, 2019	SELL	$174.11 - $208.62 $65,639 - $78,649	-377 Reduced 2.85%	12,865 $2.49 Million
Q2 2019 Aug 05, 2019	BUY	$166.7 - $195.41 $113,189 - $132,683	679 Added 5.4%	13,242 $2.44 Million
Q1 2019 May 03, 2019	BUY	$180.87 - $203.88 $116,842 - $131,706	646 Added 5.42%	12,563 $2.39 Million
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $34,609 - $40,400	-194 Reduced 1.6%	11,917 $2.32 Million
Q3 2018 Oct 23, 2018	BUY	$185.29 - $208.89 $4,076 - $4,595	22 Added 0.18%	12,111 $2.51 Million
Q2 2018 Jul 23, 2018	BUY	$166.05 - $186.51 $418,446 - $470,005	2,520 Added 26.34%	12,089 $2.23 Million
Q1 2018 Apr 26, 2018	BUY	$169.43 - $198.0 $5,930 - $6,930	35 Added 0.37%	9,569 $1.63 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $39,665 - $44,318	-235 Reduced 2.41%	9,534 $1.66 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $1.63 Million - $1.87 Million	9,769	9,769 $1.82 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brave Asset Management Inc with notifications on news.

Account

Brave Asset Management Inc Amgen Inc Transaction History